Singapore markets close in 3 hours 2 minutes

Orphazyme A/S (1TB.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.0916-0.0034 (-3.58%)
At close: 08:06AM CET

Orphazyme A/S

Ole Maaløes Vej 3
Copenhagen 2200
45 70 70 29 80

Full-time employees1

Key executives

NameTitlePayExercisedYear born
Jennifer Jean McCannPresident of Orphazyme US, Inc.N/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.

Corporate governance

Orphazyme A/S’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.